Variants in genes affecting peptide sensitivitysuch as GLP1R and GIPR pathwaysinfluence how strongly you respond to GLP-1 and how quickly appetite returns when you stop
GSH levels influenced by erastin
With the advent of groundbreaking medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), you no longer have to rely solely on diet and exercise to reach your goals
doi: 10.1100/tsw.2006.179
Authors also like to acknowledge the UWA CMCA, the NFRMI grant, the Scanning Electron Microscope at the John de Laeter Research Centre, and the Curtin Medical Research Institute, Faculty of Health Sciences, Curtin University, W.A., Australia
Clinical trials show most patients begin noticing appetite reduction within 2-3 weeks, though visible weight loss typically becomes apparent after 4-6 weeks of consistent use